'Beyond its potential to enhance surgical resectability of the primary tumor, neoadjuvant immunotherapy further seeks to utilize the primary tumor as a source of antigens recognized by the immune system, inducing or enhancing systemic anti-tumor immunity to target and eliminate distant micrometastases that would otherwise become the nidus of post-surgical relapse'
#Immunology #immunotherapy

https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00251-9